3361 - 3370 of 6255 Results
Title
Year
-
OPENTitle: Nanobodies as allosteric modulators of Parkinson’s disease–associated LRRK2Journal Name: Proceedings of the National Academy of SciencesPublisher: Proceedings of the National Academy of SciencesVol: 119Issue #: 9Start Page:End Page:Publication Date:Open Access(OA) Status: OPENLicense: cc-by-nc-ndDOI - Digital Object Identifier: 10.1073/pnas.2112712119Best OA location URL: https://research.rug.nl/en/publications/2dd21a81-bba8-4531-aab2-e50105663eadCitation Count: 44
-
OPENTitle: Is the MC1R variant p.R160W associated with Parkinson's?Journal Name: Annals of NeurologyPublisher: WileyVol: 79Issue #: 1Start Page: 159End Page: 161Publication Date:Open Access(OA) Status: OPENLicense:DOI - Digital Object Identifier: 10.1002/ana.24527Best OA location URL: http://doi.org/10.1002/ana.24527Citation Count: 18
-
OPENTitle: Neurophysics Assessment of the Muscle Bioenergy Generated by Transcranial Magnetic StimulationJournal Name: ResearchPublisher: American Association for the Advancement of Science (AAAS)Vol: 2019Issue #:Start Page: 1End Page: 9Publication Date:Open Access(OA) Status: OPENLicense: cc-byDOI - Digital Object Identifier: 10.1155/2019/7109535Best OA location URL: https://doi.org/10.1155/2019/7109535Citation Count: 1
- Letter in response to Cole-Hunter et al., 2023: What does “Parkinson’s disease mortality” mean?2023OPENTitle: Letter in response to Cole-Hunter et al., 2023: What does “Parkinson’s disease mortality” mean?Journal Name: Environment InternationalPublisher: Elsevier BVVol: 173Issue #:Start Page: 107852End Page: 107852Publication Date:Open Access(OA) Status: OPENLicense: cc-byDOI - Digital Object Identifier: 10.1016/j.envint.2023.107852Best OA location URL: https://doi.org/10.1016/j.envint.2023.107852Citation Count: 1
-
OPENTitle: Silencing Alpha Synuclein in Mature Nigral Neurons Results in Rapid Neuroinflammation and Subsequent ToxicityJournal Name: Frontiers in Molecular NeurosciencePublisher: Frontiers Media SAVol: 11Issue #:Start Page:End Page:Publication Date:Open Access(OA) Status: OPENLicense: cc-byDOI - Digital Object Identifier: 10.3389/fnmol.2018.00036Best OA location URL: https://www.frontiersin.org/articles/10.3389/fnmol.2018.00036/pdfCitation Count: 92
-
OPENTitle: PFTK1 kinase regulates axogenesis during development via RhoA activationJournal Name: BMC BiologyPublisher: Springer Science and Business Media LLCVol: 21Issue #: 1Start Page:End Page:Publication Date:Open Access(OA) Status: OPENLicense: cc-byDOI - Digital Object Identifier: 10.1186/s12915-023-01732-wBest OA location URL: https://bmcbiol.biomedcentral.com/counter/pdf/10.1186/s12915-023-01732-wCitation Count: 2
-
OPENTitle: Alpha-synuclein suppresses mitochondrial protease ClpP to trigger mitochondrial oxidative damage and neurotoxicityJournal Name: Acta NeuropathologicaPublisher: Springer Science and Business Media LLCVol: 137Issue #: 6Start Page: 939End Page: 960Publication Date:Open Access(OA) Status: OPENLicense: cc-byDOI - Digital Object Identifier: 10.1007/s00401-019-01993-2Best OA location URL: https://link.springer.com/content/pdf/10.1007/s00401-019-01993-2.pdfCitation Count: 76
-
OPENTitle: Regional volumetric change in Parkinson's disease with cognitive declineJournal Name: Journal of the Neurological SciencesPublisher: Elsevier BVVol: 373Issue #:Start Page: 88End Page: 94Publication Date:Open Access(OA) Status: OPENLicense: other-oaDOI - Digital Object Identifier: 10.1016/j.jns.2016.12.030Best OA location URL: https://doi.org/10.1016/j.jns.2016.12.030Citation Count: 27
- Effect of LRRK2 protein and activity on stimulated cytokines in human monocytes and macrophages2022OPENTitle: Effect of LRRK2 protein and activity on stimulated cytokines in human monocytes and macrophagesJournal Name: npj Parkinson's DiseasePublisher: Springer Science and Business Media LLCVol: 8Issue #: 1Start Page:End Page:Publication Date:Open Access(OA) Status: OPENLicense: cc-byDOI - Digital Object Identifier: 10.1038/s41531-022-00297-9Best OA location URL: https://www.nature.com/articles/s41531-022-00297-9.pdfCitation Count: 33
-
OPENTitle: Loss of kallikrein‐related peptidase 7 exacerbates amyloid pathology in Alzheimer's disease model miceJournal Name: EMBO Molecular MedicinePublisher: Springer Science and Business Media LLCVol: 10Issue #: 3Start Page:End Page:Publication Date:Open Access(OA) Status: OPENLicense: cc-byDOI - Digital Object Identifier: 10.15252/emmm.201708184Best OA location URL: https://doi.org/10.15252/emmm.201708184Citation Count: 47